| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0020-7519(02)00194-7 |
| P698 | PubMed publication ID | 12435450 |
| P50 | author | Steven R. Meshnick | Q62070963 |
| P2860 | cites work | Artemisinin, an Endoperoxide Antimalarial, Disrupts the Hemoglobin Catabolism and Heme Detoxification Systems in Malarial Parasite | Q22061847 |
| Molecular modeling studies of the artemisinin (qinghaosu)-hemin interaction: docking between the antimalarial agent and its putative receptor | Q48024666 | ||
| Effects of artemisinin derivatives on malaria transmissibility | Q48027455 | ||
| Ataxia and slurred speech after artesunate treatment for falciparum malaria | Q48036625 | ||
| Induction and isolation of artemisinine-resistant mutants of Plasmodium falciparum. | Q54450901 | ||
| Ring opening of artemisinin (qinghaosu) and dihydroartemisinin and interception of the open hydroperoxides with Formation of N-oxides — a chemical model for antimalarial mode of action | Q59870606 | ||
| The behaviour of qinghaosu (artemisinin) in the presence of heme iron(II) and (III) | Q59870621 | ||
| Hemin-catalyzed decomposition of artemisinin (qinghaosu) | Q68109840 | ||
| The antimalarial action on Plasmodium falciparum of qinghaosu and artesunate in combination with agents which modulate oxidant stress | Q68236209 | ||
| Stage specific actions of antimalarial drugs on Plasmodium falciparum in culture | Q69491793 | ||
| Atovaquone in the treatment of Babesia microti infections in hamsters | Q71466000 | ||
| Reaction between ferriprotoporphyrin IX and the antimalarial endoperoxide artesunate gives an intermediate species with enhanced redox catalytic activity | Q71815492 | ||
| Further Evidence Supporting the Importance of and the Restrictions on a Carbon-Centered Radical for High Antimalarial Activity of 1,2,4-Trioxanes Like Artemisinin | Q71871177 | ||
| Alkylation of proteins by artemisinin. Effects of heme, pH, and drug structure | Q72145515 | ||
| The toxicity of artemisinin and related compounds on neuronal and glial cells in culture | Q72236509 | ||
| Mechanism-based design, synthesis, and in vitro antimalarial testing of new 4-methylated trioxanes structurally related to artemisinin: the importance of a carbon-centered radical for antimalarial activity | Q72405730 | ||
| Morphologic effects of artemisinin in Plasmodium falciparum | Q72542894 | ||
| Alkylation of human albumin by the antimalarial artemisinin | Q72870627 | ||
| Correlation of antimalarial activity of artemisinin derivatives with binding affinity with ferroprotoporphyrin IX | Q73126615 | ||
| Artemisinin enhances heme-catalysed oxidation of lipid membranes | Q73212284 | ||
| Ferryl-oxo heme intermediate in the antimalarial mode of action of artemisinin | Q73851164 | ||
| Comparison of 3D quantitative structure-activity relationship methods: analysis of the in vitro antimalarial activity of 154 artemisinin analogues by hypothetical active-site lattice and comparative molecular field analysis | Q74835547 | ||
| EPR evidence for the involvement of free radicals in the iron-catalysed decomposition of qinghaosu (artemisinin) and some derivatives; antimalarial action of some polycyclic endoperoxides | Q77083696 | ||
| Assessment of the pharmacodynamic properties of antimalarial drugs in vivo | Q24670346 | ||
| Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum | Q27861931 | ||
| The Plasmodium falciparum translationally controlled tumor protein homolog and its reaction with the antimalarial drug artemisinin | Q28274190 | ||
| The Plasmodium falciparum translationally controlled tumor protein: subcellular localization and calcium binding | Q30039014 | ||
| Adverse effects in patients with acute falciparum malaria treated with artemisinin derivatives | Q33646966 | ||
| Reaction of antimalarial endoperoxides with specific parasite proteins | Q33757165 | ||
| Artemisinin derivatives for treating uncomplicated malaria | Q33908651 | ||
| Artemether-lumefantrine for the treatment of multidrug-resistant falciparum malaria | Q33929311 | ||
| Mechanisms of artemisinin resistance in the rodent malaria pathogen Plasmodium yoelii | Q33978709 | ||
| In vitro and in vivo potentiation of artemisinin and synthetic endoperoxide antimalarial drugs by metalloporphyrins | Q33980800 | ||
| Hemoglobin catabolism and iron utilization by malaria parasites | Q34415972 | ||
| The potential of artemether for the control of schistosomiasis | Q34455017 | ||
| Antimalarial drug resistance and combination chemotherapy | Q35212414 | ||
| The mechanisms of parasite clearance after antimalarial treatment of Plasmodium falciparum malaria | Q38945844 | ||
| Increased sensitivity to the antimalarials mefloquine and artemisinin is conferred by mutations in the pfmdr1 gene of Plasmodium falciparum | Q38980049 | ||
| Studies of the neurotoxicity of oral artemisinin derivatives in mice. | Q39308519 | ||
| Assessment of the neurotoxicity of parenteral artemisinin derivatives in mice | Q39308526 | ||
| Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study | Q39309831 | ||
| The pfmdr1 gene is associated with a multidrug-resistant phenotype in Plasmodium falciparum from the western border of Thailand. | Q39472395 | ||
| Immunoprecipitation of [(3)H]dihydroartemisinin translationally controlled tumor protein (TCTP) adducts from Plasmodium falciparum-infected erythrocytes by using anti-TCTP antibodies | Q39478101 | ||
| Artesunate reduces but does not prevent posttreatment transmission of Plasmodium falciparum to Anopheles gambiae. | Q39511728 | ||
| Plasmodium falciparum: in vitro studies of the pharmacodynamic properties of drugs used for the treatment of severe malaria | Q39517554 | ||
| Neurotoxic mode of action of artemisinin | Q39653002 | ||
| Iron-dependent free radical generation from the antimalarial agent artemisinin (qinghaosu). | Q39866015 | ||
| The chemotherapy of rodent malaria, XL. The action of artemisinin and related sesquiterpenes | Q41914989 | ||
| Qinghaosu-induced changes in the morphology of Plasmodium inui. | Q41917102 | ||
| Alternative mutations at position 76 of the vacuolar transmembrane protein PfCRT are associated with chloroquine resistance and unique stereospecific quinine and quinidine responses in Plasmodium falciparum | Q41918212 | ||
| In vitro susceptibility of Plasmodium falciparum isolates in Vietnam to artemisinin derivatives and other antimalarials | Q41929149 | ||
| In vitro stage-specific sensitivity of Plasmodium falciparum to quinine and artemisinin drugs | Q41930870 | ||
| Effects of antimalarials and protease inhibitors on plasmodial hemozoin production | Q41934587 | ||
| Stage-specific gametocytocidal effect in vitro of the antimalaria drug qinghaosu on Plasmodium falciparum | Q41944750 | ||
| Enhancement of hemin-induced membrane damage by artemisinin | Q42497034 | ||
| Apparent drug failure following artesunate treatment of Plasmodium falciparum malaria in Freetown, Sierra Leone: four case reports | Q43697040 | ||
| Structure-activity relationships of the antimalarial agent artemisinin. 6. The development of predictive in vitro potency models using CoMFA and HQSAR methodologies | Q43849708 | ||
| Artemisinin (qinghaosu)--a new gametocytocidal drug for malaria | Q44147893 | ||
| Artemisinin derivatives in the treatment of falciparum malaria in pregnancy | Q44514584 | ||
| Alkylating capacity and reaction products of antimalarial trioxanes after activation by a heme model | Q45713615 | ||
| Artemisinin (qinghaosu): the role of intracellular hemin in its mechanism of antimalarial action | Q47308607 | ||
| Thalassaemia trait, red blood cell age and oxidant stress: effects on Plasmodium falciparum growth and sensitivity to artemisinin. | Q47826078 | ||
| Two patients with falciparum malaria and poor in vivo responses to artesunate | Q47847492 | ||
| Qinghaosu, dietary vitamin E, selenium, and cod-liver oil: effect on the susceptibility of mice to the malarial parasite Plasmodium yoelii | Q47898085 | ||
| Arteether, a new antimalarial drug: synthesis and antimalarial properties | Q47910630 | ||
| The interaction of artemisinin with malarial hemozoin | Q48016192 | ||
| P433 | issue | 13 | |
| P921 | main subject | artemisinin | Q426921 |
| P304 | page(s) | 1655-1660 | |
| P577 | publication date | 2002-12-01 | |
| P1433 | published in | International Journal for Parasitology | Q6051284 |
| P1476 | title | Artemisinin: mechanisms of action, resistance and toxicity | |
| P478 | volume | 32 |
| Q34602021 | 21st century natural product research and drug development and traditional medicines |
| Q61815491 | A Microbial Transformation Model for Simulating Mammal Metabolism of Artemisinin |
| Q49973010 | A minimalistic approach to develop new anti-apicomplexa polyamines analogs |
| Q37734608 | A mitochondria-targeting artemisinin derivative with sharply increased antitumor but depressed anti-yeast and anti-malaria activities |
| Q38998772 | A randomised trial to assess the efficacy and safety of chlorproguanil/dapsone + artesunate for the treatment of uncomplicated Plasmodium falciparum malaria |
| Q38194450 | A review of dihydroartemisinin as another gift from traditional Chinese medicine not only for malaria control but also for schistosomiasis control |
| Q46925199 | A study on antimalarial artemisinin derivatives using MEP maps and multivariate QSAR. |
| Q37138144 | Accumulation of artemisinin trioxane derivatives within neutral lipids of Plasmodium falciparum malaria parasites is endoperoxide-dependent |
| Q38089167 | Advances in the discovery and development of trematocidal drugs |
| Q30632070 | Agglomerated oral dosage forms of artemisinin/β-cyclodextrin spray-dried primary microparticles showing increased dissolution rate and bioavailability |
| Q99545663 | Alzheimer's disease: natural products as inhibitors of neuroinflammation |
| Q36222756 | Anti-malarial effect of semi-synthetic drug amitozyn |
| Q37626137 | Anticancer activities of artemisinin and its bioactive derivatives |
| Q35725562 | Antimalarial Effects of Iranian Flora Artemisia sieberi on Plasmodium berghei In Vivo in Mice and Phytochemistry Analysis of Its Herbal Extracts |
| Q47972484 | Antimalarial activity of artemisinins: identification of a novel target? |
| Q38967366 | Antimalarial activity of betulinic acid and derivatives in vitro against Plasmodium falciparum and in vivo in P. berghei-infected mice |
| Q35840382 | Antimalarial combinations |
| Q36571059 | Antimalarial quinolones: synthesis, potency, and mechanistic studies |
| Q57612880 | Antiparasitic activity of chicory (Cichorium intybus) and its natural bioactive compounds in livestock: a review |
| Q35238319 | Antiparasitic chemotherapy: from genomes to mechanisms |
| Q45959492 | Application of the linear interaction energy method for rational design of artemisinin analogues as haeme polymerisation inhibitors. |
| Q28276294 | Artemisinin Action and Resistance in Plasmodium falciparum |
| Q90115403 | Artemisinin Protects Human Retinal Pigmented Epithelial Cells Against Hydrogen Peroxide-induced Oxidative Damage by Enhancing the Activation of AMP-active Protein Kinase |
| Q35105092 | Artemisinin activity against Plasmodium falciparum requires hemoglobin uptake and digestion |
| Q28536780 | Artemisinin analogues as potent inhibitors of in vitro hepatitis C virus replication |
| Q22061805 | Artemisinin and a Series of Novel Endoperoxide Antimalarials Exert Early Effects on Digestive Vacuole Morphology |
| Q44910071 | Artemisinin and heme |
| Q39138866 | Artemisinin as a Chinese medicine, selectively induces apoptosis in pancreatic tumor cell line |
| Q38042732 | Artemisinin derivatives: a patent review (2006 - present). |
| Q46184684 | Artemisinin induces hormonal imbalance and oxidative damage in the erythrocytes and uterus but not in the ovary of rats. |
| Q38725091 | Artemisinin inhibits inflammatory response via regulating NF-κB and MAPK signaling pathways |
| Q46290731 | Artemisinin reduces human melanoma cell migration by down-regulating alpha V beta 3 integrin and reducing metalloproteinase 2 production |
| Q36610773 | Artemisinin resistance in Plasmodium falciparum: A process linked to dormancy? |
| Q34231069 | Artemisinin triggers a G1 cell cycle arrest of human Ishikawa endometrial cancer cells and inhibits cyclin-dependent kinase-4 promoter activity and expression by disrupting nuclear factor-κB transcriptional signaling |
| Q21032532 | Artemisinin-resistant malaria: research challenges, opportunities, and public health implications |
| Q38772717 | Artemisinins as potential anticancer agents: uptake detection in erythrocytes using Fourier transform infrared spectroscopy and cytotoxicity against bladder cancer cells. |
| Q22061877 | Artemisinins target the SERCA of Plasmodium falciparum |
| Q38855577 | Artesunate induces ROS- and p38 MAPK-mediated apoptosis and counteracts tumor growth in vivo in embryonal rhabdomyosarcoma cells |
| Q28469266 | Artesunate induces ROS-mediated apoptosis in doxorubicin-resistant T leukemia cells |
| Q33666019 | Artesunate induces oncosis-like cell death in vitro and has antitumor activity against pancreatic cancer xenografts in vivo |
| Q64232050 | Assessment of Artemisinin Contents in Selected Species from Tajikistan (Central Asia) |
| Q37718555 | Biological actions of artemisinin: insights from medicinal chemistry studies |
| Q34473796 | Brazilian Plasmodium falciparum isolates: investigation of candidate polymorphisms for artemisinin resistance before introduction of artemisinin-based combination therapy |
| Q38446306 | Capacity building in anthelmintic drug discovery |
| Q93271193 | Cellular thermal shift assay for the identification of drug-target interactions in the Plasmodium falciparum proteome |
| Q46758736 | Clinical pharmacokinetics of the diastereomers of arteether in healthy volunteers |
| Q37227733 | Co-ordinated stage-dependent enhancement of Plasmodium falciparum antioxidant enzymes and heat shock protein expression in parasites growing in oxidatively stressed or G6PD-deficient red blood cells |
| Q107038883 | Cognate and cognitive ecopharmacognosy — in an anthropogenic era |
| Q41970025 | Comparative antimalarial activities of six pairs of 1,2,4,5-tetraoxanes (peroxide dimers) and 1,2,4,5,7,8-hexaoxonanes (peroxide trimers). |
| Q30497710 | Cryo transmission X-ray imaging of the malaria parasite, P. falciparum. |
| Q37735182 | Current knowledge and challenges of antimalarial drugs for treatment and prevention in pregnancy |
| Q38774777 | Current status of synthetic hemozoin adjuvant: A preliminary safety evaluation. |
| Q34611440 | De Novo transcriptome assembly (NGS) of Curcuma longa L. rhizome reveals novel transcripts related to anticancer and antimalarial terpenoids |
| Q27973107 | Deconvoluting heme biosynthesis to target blood-stage malaria parasites |
| Q28478307 | Development of resistance towards artesunate in MDA-MB-231 human breast cancer cells |
| Q39675027 | Dihydroartemisinin Induces Apoptosis by a Bak-Dependent Intrinsic Pathway |
| Q34292461 | Dihydroartemisinin enhances Apo2L/TRAIL-mediated apoptosis in pancreatic cancer cells via ROS-mediated up-regulation of death receptor 5 |
| Q36811863 | Dihydroartemisinin induces autophagy and inhibits the growth of iron-loaded human myeloid leukemia K562 cells via ROS toxicity |
| Q39594720 | Dihydroartemisinin induces caspase-8-dependent apoptosis in murine GT1-7 hypothalamic neurons. |
| Q50145429 | Dihydroartemisinin inhibits colon cancer cell viability by inducing apoptosis through up-regulation of PPARγ expression |
| Q39921071 | Dihydroartemisinin is a Hypoxia-Active Anti-Cancer Drug in Colorectal Carcinoma Cells |
| Q34740860 | Dihydroartemisinin promotes angiogenesis during the early embryonic development of zebrafish |
| Q38949261 | Dihydroartemisinin suppresses glioma proliferation and invasion via inhibition of the ADAM17 pathway |
| Q50053462 | Dihydroartemisinin treatment of multiple myeloma cells causes activation of c-Jun leading to cell apoptosis |
| Q35006418 | Discovery, mechanisms of action and combination therapy of artemisinin |
| Q28484494 | Dried whole plant Artemisia annua as an antimalarial therapy |
| Q36248426 | Drug-resistant malaria |
| Q39744038 | Effect of artemisinin derivatives on apoptosis and cell cycle in prostate cancer cells |
| Q50596355 | Effect of oral coadministration of artesunate with ferrous sulfate on rat liver mitochondrial membrane permeability transition. |
| Q40197611 | Effects of artemisinin and its derivatives on growth inhibition and apoptosis of oral cancer cells. |
| Q37962462 | Effects of artemisinins on reticulocyte count and relationship to possible embryotoxicity in confirmed and unconfirmed malarial patients |
| Q39576151 | Efficacy of artemether and artesunate in mice infected with praziquantel non-susceptible isolate of Schistosoma japonicum |
| Q39021961 | Efflux as a mechanism of antimicrobial drug resistance in clinical relevant microorganisms: the role of efflux inhibitors |
| Q37326475 | Embryotoxicity and toxicokinetics of the antimalarial artesunate in rats |
| Q38710983 | Emerging Anti-Mitotic Activities and Other Bioactivities of Sesquiterpene Compounds upon Human Cells. |
| Q34343530 | Emerging artemisinin resistance in the border areas of Thailand |
| Q36118255 | Emerging issues in traditional Chinese medicine |
| Q28077102 | Endoperoxide antimalarials: development, structural diversity and pharmacodynamic aspects with reference to 1,2,4-trioxane-based structural scaffold |
| Q43654854 | Engineering dynamic pathway regulation using stress-response promoters. |
| Q90150657 | Enhancement Effect of Shark Cartilage Extract on Treatment of Leishmania infantum with Artemisinin and Glucantime and Evaluation of killing Factors and Apoptosis in-vitro Condition |
| Q33743694 | Ergosterol isolated from the basidiomycete Pleurotus salmoneostramineus affects Trypanosoma cruzi plasma membrane and mitochondria. |
| Q64235017 | Evaluation of synergistic therapeutic effect of shark cartilage extract with artemisinin and glucantime on visceral leishmaniasis in BALB/c mice |
| Q28748825 | Evaluation of the effect of pyrimethamine, an anti-malarial drug, on HIV-1 replication |
| Q39491810 | Evidence for a common non-heme chelatable-iron-dependent activation mechanism for semisynthetic and synthetic endoperoxide antimalarial drugs. |
| Q41913431 | Evidence that haem iron in the malaria parasite is not needed for the antimalarial effects of artemisinin |
| Q33962805 | Exploring the contribution of candidate genes to artemisinin resistance in Plasmodium falciparum |
| Q42953817 | First Computational Evidence of a Competitive Stepwise and Concerted Mechanism for the Reduction of Antimalarial Endoperoxides |
| Q30362459 | Gene encoding a deubiquitinating enzyme is mutated in artesunate- and chloroquine-resistant rodent malaria parasites |
| Q37857748 | Genetic analysis in mice identifies cysteamine as a novel partner for artemisinin in the treatment of malaria |
| Q48875861 | Glycyrrhiza glabra (Linn.) and Lavandula officinalis (L.) cell suspension cultures-based biotransformation of β-artemether |
| Q22061870 | Haem-activated promiscuous targeting of artemisinin in Plasmodium falciparum |
| Q43857691 | Haemin enhances the in vivo efficacy of artemether against juvenile and adult Schistosoma mansoni in mice |
| Q41680593 | Hematological and biochemical effects of sub-chronic artesunate exposure in rats |
| Q30930807 | Identification and characterization of heme-interacting proteins in the malaria parasite, Plasmodium falciparum |
| Q22061876 | Identification of an antimalarial synthetic trioxolane drug development candidate |
| Q41673690 | Immunization of mice with Plasmodium TCTP delays establishment of Plasmodium infection |
| Q56384056 | Improved safety margin for embryotoxicity in rats for the new endoperoxide artefenomel (OZ439) as compared to artesunate |
| Q35757992 | In Vivo Antimalarial Effects of Iranian Flora Artemisia khorassanica against Plasmodium berghei and Pharmacochemistry of its Natural Components |
| Q37607795 | In vitro activity of anti-malarial ozonides against an artemisinin-resistant isolate |
| Q36870795 | In vitro and in vivo treatments of echinococcus protoscoleces and metacestodes with artemisinin and artemisinin derivatives |
| Q28484068 | In vitro sensitivity of Plasmodium falciparum from China-Myanmar border area to major ACT drugs and polymorphisms in potential target genes |
| Q34120984 | Intravenous artesunate for the treatment of severe malaria |
| Q42918147 | Iron enhances generation of free radicals by Artemisinin causing a caspase-independent, apoptotic death in Leishmania donovani promastigotes |
| Q51191319 | Is there a reduced sensitivity of dihydroartemisinin against praziquantel-resistant Schistosoma japonicum? |
| Q35941360 | Lack of association of the S769N mutation in Plasmodium falciparum SERCA (PfATP6) with resistance to artemisinins |
| Q28474424 | Large-scale differential proteome analysis in Plasmodium falciparum under drug treatment |
| Q30409402 | Ligand binding reveals a role for heme in translationally-controlled tumor protein dimerization |
| Q37599856 | Malaria and iron: history and review |
| Q34352253 | Malaria parasites can develop stable resistance to artemisinin but lack mutations in candidate genes atp6 (encoding the sarcoplasmic and endoplasmic reticulum Ca2+ ATPase), tctp, mdr1, and cg10. |
| Q39122575 | Malaria treatment using novel nano-based drug delivery systems |
| Q38495295 | Mangrove dolabrane-type of diterpenes tagalsins suppresses tumor growth via ROS-mediated apoptosis and ATM/ATR-Chk1/Chk2-regulated cell cycle arrest |
| Q47974291 | Mechanism-Guided Design and Synthesis of a Mitochondria-Targeting Artemisinin Analogue with Enhanced Anticancer Activity |
| Q35821436 | Mechanisms of Dihydroartemisinin and Dihydroartemisinin/Holotransferrin Cytotoxicity in T-Cell Lymphoma Cells |
| Q35666811 | Mechanisms of in situ activation for peroxidic antimalarials |
| Q36269058 | Mechanisms of in vitro resistance to dihydroartemisinin in Plasmodium falciparum |
| Q40107073 | Mechanistic Investigation of the Specific Anticancer Property of Artemisinin and Its Combination with Aminolevulinic Acid for Enhanced Anticolorectal Cancer Activity |
| Q28743626 | Merging traditional Chinese medicine with modern drug discovery technologies to find novel drugs and functional foods |
| Q41119883 | Metabolic Dysregulation Induced in Plasmodium falciparum by Dihydroartemisinin and Other Front-Line Antimalarial Drugs |
| Q41775053 | Molecular modeling and evaluation of binding mode and affinity of artemisinin-quinine hybrid and its congeners with Fe-protoporphyrin-IX as a putative receptor |
| Q36766577 | Monitoring antimalarial safety and tolerability in clinical trials: a case study from Uganda |
| Q36478925 | Monoclonal Antibodies That Recognize the Alkylation Signature of Antimalarial Ozonides OZ277 (Arterolane) and OZ439 (Artefenomel). |
| Q37642172 | Morphological Effects of Natural Products on Schizosaccharomyces pombe Measured by Imaging Flow Cytometry |
| Q42992876 | Mosquito phenoloxidase and defensin colocalize in melanization innate immune responses. |
| Q64119795 | Nano-biotechnology: a new approach to treat and prevent malaria |
| Q57465375 | Nanomedicines for Malaria Chemotherapy: Encapsulation vs. Polymer Therapeutics |
| Q46929733 | Neurotoxicity and toxicokinetics of artelinic acid following repeated oral administration in rats |
| Q37697414 | New Insights toward Colorectal Cancer Chemotherapy Using Natural Bioactive Compounds. |
| Q37615897 | New medicines to improve control and contribute to the eradication of malaria |
| Q34487170 | Next generation sequencing and de novo transcriptome analysis of Costus pictus D. Don, a non-model plant with potent anti-diabetic properties |
| Q38671679 | Novel Plasmodium falciparum metabolic network reconstruction identifies shifts associated with clinical antimalarial resistance |
| Q30359589 | Novel multiarm polyethylene glycol-dihydroartemisinin conjugates enhancing therapeutic efficacy in non-small-cell lung cancer. |
| Q47965977 | Novel series of 1,2,4-trioxane derivatives as antimalarial agents |
| Q21284494 | Occurrence of pfatpase6 Single Nucleotide Polymorphisms Associated with Artemisinin Resistance among Field Isolates of Plasmodium falciparum in North-Eastern Tanzania |
| Q52655962 | Oxidative stress and protein damage responses mediate artemisinin resistance in malaria parasites. |
| Q39115683 | Peroxide bond-dependent antiplasmodial specificity of artemisinin and OZ277 (RBx11160). |
| Q34669043 | Pharmacokinetics and pharmacodynamics of artesunate and dihydroartemisinin following oral treatment in pregnant women with asymptomatic Plasmodium falciparum infections in Kinshasa DRC. |
| Q37428688 | Pharmacokinetics of the Antischistosomal Lead Ozonide OZ418 in Uninfected Mice Determined by Liquid Chromatography-Tandem Mass Spectrometry |
| Q34678568 | Plasmodium drug targets outside the genetic control of the parasite |
| Q33555297 | Plasmodium falciparum K13 Mutations Differentially Impact Ozonide Susceptibility and Parasite Fitness In Vitro |
| Q38129536 | Plasmodium falciparum gametocytes: with a view to a kill. |
| Q38624931 | Plasmodium falciparum kelch 13: a potential molecular marker for tackling artemisinin-resistant malaria parasites |
| Q40051806 | Population Pharmacokinetic and Pharmacodynamic Modeling of Artemisinin Resistance in Southeast Asia |
| Q60934928 | Potential of Vitamin E Deficiency, Induced by Inhibition of α-Tocopherol Efflux, in Murine Malaria Infection |
| Q93129284 | Pre-clinical study of iron oxide nanoparticles fortified artesunate for efficient targeting of malarial parasite |
| Q42147730 | Preparation and characterization of micronized artemisinin via a Rapid Expansion of Supercritical Solutions (RESS) Method |
| Q39014626 | Probing the antimalarial mechanism of artemisinin and OZ277 (arterolane) with nonperoxidic isosteres and nitroxyl radicals |
| Q37260478 | Probucol dramatically enhances dihydroartemisinin effect in murine malaria |
| Q52646479 | Profiling of the anti-malarial drug candidate SC83288 against artemisinins in Plasmodium falciparum. |
| Q36895758 | Prospects for the treatment of drug-resistant malaria parasites. |
| Q28469106 | Randomized dose-ranging controlled trial of AQ-13, a candidate antimalarial, and chloroquine in healthy volunteers |
| Q43127250 | Re-evaluation of how artemisinins work in light of emerging evidence of in vitro resistance |
| Q36284493 | Recent advances in the search for antiviral agents against human papillomaviruses. |
| Q41934930 | Reinvestigation of structure–activity relationship of methoxylated chalcones as antimalarials: Synthesis and evaluation of 2,4,5-trimethoxy substituted patterns as lead candidates derived from abundantly available natural β-asarone |
| Q41921677 | Relationship between antimalarial activity and heme alkylation for spiro- and dispiro-1,2,4-trioxolane antimalarials |
| Q37144854 | Role of known molecular markers of resistance in the antimalarial potency of piperaquine and dihydroartemisinin in vitro |
| Q44377255 | Schistosoma japonicum: In vitro effects of artemether combined with haemin depend on cultivation media and appraisal of artemether products appearing in the media |
| Q36459174 | Schistosomiasis--a century searching for chemotherapeutic drugs. |
| Q39607489 | Selection and reversal of Plasmodium berghei resistance in the mouse model following repeated high doses of artemether |
| Q35827084 | Semi-mechanistic pharmacokinetic/pharmacodynamic modelling of the antimalarial effect of artemisinin |
| Q42272265 | Stability and antiviral activity against human cytomegalovirus of artemisinin derivatives. |
| Q41912806 | Stability of peroxide antimalarials in the presence of human hemoglobin |
| Q36584903 | Structure- and function-based design of Plasmodium-selective proteasome inhibitors |
| Q90061776 | Structure-Activity Relationship of Antischistosomal Ozonide Carboxylic Acids |
| Q42343450 | Synergistic Anticancer Activities of Natural Substances in Human Hepatocellular Carcinoma |
| Q42923682 | Synergistic inhibition of angiogenesis by artesunate and captopril in vitro and in vivo |
| Q38262467 | Synthetic chemistry fuels interdisciplinary approaches to the production of artemisinin |
| Q34693880 | Synthetic ozonide drug candidate OZ439 offers new hope for a single-dose cure of uncomplicated malaria |
| Q36268319 | Targeted treatment of cancer with artemisinin and artemisinin-tagged iron-carrying compounds |
| Q37777759 | Targeting apoptosis pathways in cancer by Chinese medicine |
| Q46847377 | Tetraoxanes as a new class of efficient herbicides comparable with commercial products |
| Q28551177 | The Interactions of P-Glycoprotein with Antimalarial Drugs, Including Substrate Affinity, Inhibition and Regulation |
| Q38943630 | The Role of Natural Products in Drug Discovery and Development against Neglected Tropical Diseases |
| Q39649197 | The antimalarial agent artesunate possesses anticancer properties that can be enhanced by combination strategies. |
| Q34015782 | The antimalarial drug artemisinin alkylates heme in infected mice |
| Q37242654 | The antiviral activities of artemisinin and artesunate. |
| Q35838600 | Therapy of falciparum malaria in sub-saharan Africa: from molecule to policy |
| Q28253420 | Toxicity evaluation of artesunate and artelinate in Plasmodium berghei-infected and uninfected rats |
| Q41747844 | Traditional Chinese Medicine (TCM) and Herbal Hepatotoxicity: RUCAM and the Role of Novel Diagnostic Biomarkers Such as MicroRNAs |
| Q36240246 | Ultrastructural and real-time microscopic changes in P. falciparum-infected red blood cells following treatment with antimalarial drugs |
| Q88631509 | What has traditional Chinese medicine delivered for modern medicine? |
| Q21145281 | Yeast model uncovers dual roles of mitochondria in action of artemisinin |
Search more.